Report cover image

Global Pain-relieving API Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20362155

Description

Summary

According to APO Research, The global Pain-relieving API market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pain-relieving API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pain-relieving API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pain-relieving API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pain-relieving API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pain-relieving API include Xinhua Pharmaceutical, Sanofi, Biocause Heilen, SOLARA, SI Group, Noramco, IOLCP, Biocause and BASF, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pain-relieving API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pain-relieving API, also provides the sales of main regions and countries. Of the upcoming market potential for Pain-relieving API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain-relieving API sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pain-relieving API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pain-relieving API sales, projected growth trends, production technology, application and end-user industry.

Pain-relieving API Segment by Company

Xinhua Pharmaceutical
Sanofi
Biocause Heilen
SOLARA
SI Group
Noramco
IOLCP
Biocause
BASF
Aspen API The Netherlands
Pain-relieving API Segment by Type

Opiate
Non-Opiate
Pain-relieving API Segment by Application

Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Pain-relieving API Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain-relieving API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain-relieving API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain-relieving API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pain-relieving API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pain-relieving API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain-relieving API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Pain-relieving API Market by Type
1.2.1 Global Pain-relieving API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Opiate
1.2.3 Non-Opiate
1.3 Pain-relieving API Market by Application
1.3.1 Global Pain-relieving API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Contract Manufacturing Organizations
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pain-relieving API Market Dynamics
2.1 Pain-relieving API Industry Trends
2.2 Pain-relieving API Industry Drivers
2.3 Pain-relieving API Industry Opportunities and Challenges
2.4 Pain-relieving API Industry Restraints
3 Global Market Growth Prospects
3.1 Global Pain-relieving API Revenue Estimates and Forecasts (2020-2031)
3.2 Global Pain-relieving API Revenue by Region
3.2.1 Global Pain-relieving API Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Pain-relieving API Revenue by Region (2020-2025)
3.2.3 Global Pain-relieving API Revenue by Region (2026-2031)
3.2.4 Global Pain-relieving API Revenue Market Share by Region (2020-2031)
3.3 Global Pain-relieving API Sales Estimates and Forecasts 2020-2031
3.4 Global Pain-relieving API Sales by Region
3.4.1 Global Pain-relieving API Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Pain-relieving API Sales by Region (2020-2025)
3.4.3 Global Pain-relieving API Sales by Region (2026-2031)
3.4.4 Global Pain-relieving API Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Pain-relieving API Revenue by Manufacturers
4.1.1 Global Pain-relieving API Revenue by Manufacturers (2020-2025)
4.1.2 Global Pain-relieving API Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Pain-relieving API Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Pain-relieving API Sales by Manufacturers
4.2.1 Global Pain-relieving API Sales by Manufacturers (2020-2025)
4.2.2 Global Pain-relieving API Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Pain-relieving API Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Pain-relieving API Sales Price by Manufacturers (2020-2025)
4.4 Global Pain-relieving API Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Pain-relieving API Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pain-relieving API Manufacturers, Product Type & Application
4.7 Global Pain-relieving API Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Pain-relieving API Market CR5 and HHI
4.8.2 2024 Pain-relieving API Tier 1, Tier 2, and Tier 3
5 Pain-relieving API Market by Type
5.1 Global Pain-relieving API Revenue by Type
5.1.1 Global Pain-relieving API Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Pain-relieving API Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Pain-relieving API Revenue Market Share by Type (2020-2031)
5.2 Global Pain-relieving API Sales by Type
5.2.1 Global Pain-relieving API Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Pain-relieving API Sales by Type (2020-2031) & (K Units)
5.2.3 Global Pain-relieving API Sales Market Share by Type (2020-2031)
5.3 Global Pain-relieving API Price by Type
6 Pain-relieving API Market by Application
6.1 Global Pain-relieving API Revenue by Application
6.1.1 Global Pain-relieving API Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Pain-relieving API Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Pain-relieving API Revenue Market Share by Application (2020-2031)
6.2 Global Pain-relieving API Sales by Application
6.2.1 Global Pain-relieving API Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Pain-relieving API Sales by Application (2020-2031) & (K Units)
6.2.3 Global Pain-relieving API Sales Market Share by Application (2020-2031)
6.3 Global Pain-relieving API Price by Application
7 Company Profiles
7.1 Xinhua Pharmaceutical
7.1.1 Xinhua Pharmaceutical Comapny Information
7.1.2 Xinhua Pharmaceutical Business Overview
7.1.3 Xinhua Pharmaceutical Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Xinhua Pharmaceutical Pain-relieving API Product Portfolio
7.1.5 Xinhua Pharmaceutical Recent Developments
7.2 Sanofi
7.2.1 Sanofi Comapny Information
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sanofi Pain-relieving API Product Portfolio
7.2.5 Sanofi Recent Developments
7.3 Biocause Heilen
7.3.1 Biocause Heilen Comapny Information
7.3.2 Biocause Heilen Business Overview
7.3.3 Biocause Heilen Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Biocause Heilen Pain-relieving API Product Portfolio
7.3.5 Biocause Heilen Recent Developments
7.4 SOLARA
7.4.1 SOLARA Comapny Information
7.4.2 SOLARA Business Overview
7.4.3 SOLARA Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 SOLARA Pain-relieving API Product Portfolio
7.4.5 SOLARA Recent Developments
7.5 SI Group
7.5.1 SI Group Comapny Information
7.5.2 SI Group Business Overview
7.5.3 SI Group Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 SI Group Pain-relieving API Product Portfolio
7.5.5 SI Group Recent Developments
7.6 Noramco
7.6.1 Noramco Comapny Information
7.6.2 Noramco Business Overview
7.6.3 Noramco Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Noramco Pain-relieving API Product Portfolio
7.6.5 Noramco Recent Developments
7.7 IOLCP
7.7.1 IOLCP Comapny Information
7.7.2 IOLCP Business Overview
7.7.3 IOLCP Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 IOLCP Pain-relieving API Product Portfolio
7.7.5 IOLCP Recent Developments
7.8 Biocause
7.8.1 Biocause Comapny Information
7.8.2 Biocause Business Overview
7.8.3 Biocause Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Biocause Pain-relieving API Product Portfolio
7.8.5 Biocause Recent Developments
7.9 BASF
7.9.1 BASF Comapny Information
7.9.2 BASF Business Overview
7.9.3 BASF Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 BASF Pain-relieving API Product Portfolio
7.9.5 BASF Recent Developments
7.10 Aspen API The Netherlands
7.10.1 Aspen API The Netherlands Comapny Information
7.10.2 Aspen API The Netherlands Business Overview
7.10.3 Aspen API The Netherlands Pain-relieving API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Aspen API The Netherlands Pain-relieving API Product Portfolio
7.10.5 Aspen API The Netherlands Recent Developments
8 North America
8.1 North America Pain-relieving API Market Size by Type
8.1.1 North America Pain-relieving API Revenue by Type (2020-2031)
8.1.2 North America Pain-relieving API Sales by Type (2020-2031)
8.1.3 North America Pain-relieving API Price by Type (2020-2031)
8.2 North America Pain-relieving API Market Size by Application
8.2.1 North America Pain-relieving API Revenue by Application (2020-2031)
8.2.2 North America Pain-relieving API Sales by Application (2020-2031)
8.2.3 North America Pain-relieving API Price by Application (2020-2031)
8.3 North America Pain-relieving API Market Size by Country
8.3.1 North America Pain-relieving API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Pain-relieving API Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Pain-relieving API Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Pain-relieving API Market Size by Type
9.1.1 Europe Pain-relieving API Revenue by Type (2020-2031)
9.1.2 Europe Pain-relieving API Sales by Type (2020-2031)
9.1.3 Europe Pain-relieving API Price by Type (2020-2031)
9.2 Europe Pain-relieving API Market Size by Application
9.2.1 Europe Pain-relieving API Revenue by Application (2020-2031)
9.2.2 Europe Pain-relieving API Sales by Application (2020-2031)
9.2.3 Europe Pain-relieving API Price by Application (2020-2031)
9.3 Europe Pain-relieving API Market Size by Country
9.3.1 Europe Pain-relieving API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Pain-relieving API Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Pain-relieving API Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Pain-relieving API Market Size by Type
10.1.1 China Pain-relieving API Revenue by Type (2020-2031)
10.1.2 China Pain-relieving API Sales by Type (2020-2031)
10.1.3 China Pain-relieving API Price by Type (2020-2031)
10.2 China Pain-relieving API Market Size by Application
10.2.1 China Pain-relieving API Revenue by Application (2020-2031)
10.2.2 China Pain-relieving API Sales by Application (2020-2031)
10.2.3 China Pain-relieving API Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Pain-relieving API Market Size by Type
11.1.1 Asia Pain-relieving API Revenue by Type (2020-2031)
11.1.2 Asia Pain-relieving API Sales by Type (2020-2031)
11.1.3 Asia Pain-relieving API Price by Type (2020-2031)
11.2 Asia Pain-relieving API Market Size by Application
11.2.1 Asia Pain-relieving API Revenue by Application (2020-2031)
11.2.2 Asia Pain-relieving API Sales by Application (2020-2031)
11.2.3 Asia Pain-relieving API Price by Application (2020-2031)
11.3 Asia Pain-relieving API Market Size by Country
11.3.1 Asia Pain-relieving API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Pain-relieving API Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Pain-relieving API Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Pain-relieving API Market Size by Type
12.1.1 SAMEA Pain-relieving API Revenue by Type (2020-2031)
12.1.2 SAMEA Pain-relieving API Sales by Type (2020-2031)
12.1.3 SAMEA Pain-relieving API Price by Type (2020-2031)
12.2 SAMEA Pain-relieving API Market Size by Application
12.2.1 SAMEA Pain-relieving API Revenue by Application (2020-2031)
12.2.2 SAMEA Pain-relieving API Sales by Application (2020-2031)
12.2.3 SAMEA Pain-relieving API Price by Application (2020-2031)
12.3 SAMEA Pain-relieving API Market Size by Country
12.3.1 SAMEA Pain-relieving API Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Pain-relieving API Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Pain-relieving API Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Pain-relieving API Value Chain Analysis
13.1.1 Pain-relieving API Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pain-relieving API Production Mode & Process
13.2 Pain-relieving API Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pain-relieving API Distributors
13.2.3 Pain-relieving API Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.